Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Enasidenib Mesylate (CAS 1246897-05-3) is a selective oral inhibitor of mutant IDH2. It features a specific synthesis route targeting N-methylated intermediates. Molecular formula: C20H24N8O·CH4O3S.
Application
- Pharmaceutical manufacturing for relapsed/refractory AML treatment.
- Clinical trials focusing on hematological malignancies.
- R&D laboratories for oncology mechanism studies.
Precautions
Strictly store below -20°C in dry conditions. Avoid direct contact due to potential toxicity. Monitor QT interval prolongation risks during clinical administration.